Abstract

Retinoic acid-related orphan receptor RORγt plays a pivotal role in the differentiation of T<sub>H</sub>17 cells. Antagonizing RORγt transcriptional activity is a potential means to treat T<sub>H</sub>17-related autoimmune diseases. Herein, we describe the identification of a series of diphenylpropanamides as novel and selective RORγ antagonists. Diphenylpropanamide <b>4n</b> inhibited the transcriptional activity of RORγt, but not RORα, in cells. In addition, it suppressed human T<sub>H</sub>17 cell differentiation at submicromolar concentrations

    Similar works

    Full text

    thumbnail-image

    Available Versions